IOF.L
Iofina plc [IOF.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
IOF.L Stock Summary
Top 10 Correlated ETFs
IOF.L
Top 10 Correlated Stocks
IOF.L
In the News
IOF.L Financial details
Company Rating
Strong Buy
Market Cap
39.91M
Income
17.11M
Revenue
85.61M
Book val./share
0.21
Cash/share
0.03
Dividend
-
Dividend %
-
Employees
95
Optionable
No
Shortable
Yes
Earnings
23 Apr 2024
P/E
8.36
Forward P/E
-
PEG
1.01
P/S
1.56
P/B
1.73
P/C
655.67
P/FCF
26.65
Quick Ratio
0.65
Current Ratio
2.93
Debt / Equity
0.15
LT Debt / Equity
0.11
-
-
EPS (TTM)
0.09
EPS next Y
-
EPS next Q
-
EPS this Y
-14.41%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
11.99%
Revenue Q/Q
5.56%
EPS Q/Q
-40%
-
-
-
-
SMA20
-9.27%
SMA50
-22.49%
SMA100
-21.13%
Inst Own
-
Inst Trans
-
ROA
15%
ROE
23%
ROC
0.22%
Gross Margin
38%
Oper. Margin
23%
Profit Margin
19%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
19.0-38.0
52W High
-48.24%
52W Low
+3.53%
RSI
39.17
Rel Volume
1.54
Avg Volume
213.84K
Volume
328.95K
Perf Week
-0.41%
Perf Month
-14.48%
Perf Quarter
-14.48%
Perf Half Y
-18.89%
-
-
-
-
Beta
0.634
-
-
Volatility
1.36%, 1.14%
Prev Close
-4.05%
Price
19.67
Change
-10.59%
IOF.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.19 | 0.16 | 0.15 | 0.2 | 0.22 | |
| Net income per share | -0.01 | 0 | 0.01 | 0.05 | 0.04 | |
| Operating cash flow per share | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | |
| Free cash flow per share | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | |
| Cash per share | 0.04 | 0.05 | 0.02 | 0.03 | 0.03 | |
| Book value per share | 0.05 | 0.11 | 0.11 | 0.16 | 0.2 | |
| Tangible book value per share | 0.01 | 0.08 | 0.09 | 0.14 | 0.18 | |
| Share holders equity per share | 0.05 | 0.11 | 0.11 | 0.16 | 0.2 | |
| Interest debt per share | 0.22 | 0.11 | 0.08 | 0.05 | 0.04 | |
| Market cap | 17.99M | 67.61M | 34M | 46.94M | 47.01M | |
| Enterprise value | 38.29M | 77.36M | 44.15M | 50.36M | 48.28M | |
| P/E ratio | -15.74 | 122.38 | 26.6 | 5.11 | 5.98 | |
| Price to sales ratio | 0.75 | 2.31 | 1.15 | 1.2 | 1.11 | |
| POCF ratio | 9.06 | 20.16 | 9 | 5.95 | 8.47 | |
| PFCF ratio | 16.68 | 40.78 | 25.62 | 7.33 | 19.08 | |
| P/B Ratio | 3.02 | 3.52 | 1.65 | 1.57 | 1.24 | |
| PTB ratio | 3.02 | 3.52 | 1.65 | 1.57 | 1.24 | |
| EV to sales | 1.6 | 2.65 | 1.49 | 1.29 | 1.14 | |
| Enterprise value over EBITDA | 16.49 | 17.87 | 9.58 | 7.36 | 4.25 | |
| EV to operating cash flow | 19.27 | 23.07 | 11.69 | 6.38 | 8.7 | |
| EV to free cash flow | 35.49 | 46.67 | 33.27 | 7.86 | 19.59 | |
| Earnings yield | -0.06 | 0.01 | 0.04 | 0.2 | 0.17 | |
| Free cash flow yield | 0.06 | 0.02 | 0.04 | 0.14 | 0.05 | |
| Debt to equity | 4.17 | 0.96 | 0.66 | 0.28 | 0.18 | |
| Debt to assets | 0.69 | 0.42 | 0.34 | 0.19 | 0.13 | |
| Net debt to EBITDA | 8.74 | 2.25 | 2.2 | 0.5 | 0.11 | |
| Current ratio | 2.94 | 0.9 | 2.13 | 2.43 | 2.93 | |
| Interest coverage | 0.13 | 1.14 | 2.63 | 14.01 | 29.58 | |
| Income quality | -1.74 | 6.07 | 2.95 | 0.86 | 0.71 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.05 | 0.04 | 0.12 | 0.1 | 0.1 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.11 | 0.09 | 0.09 | 0.08 | 0.06 | |
| Capex to operating cash flow | -0.46 | -0.51 | -0.65 | -0.19 | -0.56 | |
| Capex to revenue | -0.04 | -0.06 | -0.08 | -0.04 | -0.07 | |
| Capex to depreciation | -0.47 | -1.05 | -1.37 | -0.86 | -1.69 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0 | 0 | 0 | |
| Graham number | 0.1 | 0.08 | 0.13 | 0.41 | 0.43 | |
| ROIC | 0.02 | 0.07 | 0.08 | 0.03 | 0.17 | |
| Return on tangible assets | -0.04 | 0.01 | 0.04 | 0.22 | 0.16 | |
| Graham Net | -0.16 | -0.04 | -0.04 | -0.01 | 0.02 | |
| Working capital | 9.65M | -2.46M | 9.19M | 10.43M | 17.53M | |
| Tangible asset value | 1.8M | 15.32M | 16.93M | 26.41M | 34.6M | |
| Net current asset value | -15.56M | -2.63M | -1.86M | 3.23M | 11.86M | |
| Invested capital | 4.17 | 0.96 | 0.66 | 0.28 | 0.18 | |
| Average receivables | 4.17M | 4.77M | 4.3M | 4.38M | 7.8M | |
| Average payables | 1.33M | 1.56M | 1.33M | 1.36M | 2.02M | |
| Average inventory | 4.99M | 5.88M | 7.87M | 7.98M | 8.24M | |
| Days sales outstanding | 61.81 | 68.54 | 38.14 | 52.85 | 86.06 | |
| Days payables outstanding | 34.49 | 25.37 | 20.48 | 19.61 | 34.74 | |
| Days of inventory on hand | 117.33 | 105.63 | 165.6 | 81.18 | 140.97 | |
| Receivables turnover | 5.91 | 5.33 | 9.57 | 6.91 | 4.24 | |
| Payables turnover | 10.58 | 14.39 | 17.82 | 18.61 | 10.51 | |
| Inventory turnover | 3.11 | 3.46 | 2.2 | 4.5 | 2.59 | |
| ROE | -0.19 | 0.03 | 0.06 | 0.31 | 0.21 | |
| Capex per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.1 | 0.1 | 0.1 | 0.12 | 0.12 | |
| Net income per share | 0.02 | 0.03 | 0.01 | 0.03 | 0.02 | |
| Operating cash flow per share | 0.01 | 0.03 | 0.01 | 0.02 | 0.03 | |
| Free cash flow per share | 0.01 | 0.02 | 0 | 0.01 | 0.01 | |
| Cash per share | 0.01 | 0.03 | 0.02 | 0.03 | 0.03 | |
| Book value per share | 0.13 | 0.16 | 0.17 | 0.19 | 0.21 | |
| Tangible book value per share | 0.11 | 0.14 | 0.15 | 0.17 | 0.19 | |
| Share holders equity per share | 0.13 | 0.16 | 0.17 | 0.19 | 0.21 | |
| Interest debt per share | 0.05 | 0.04 | 0.04 | 0.03 | 0.03 | |
| Market cap | 34.31M | 46.94M | 57.62M | 48.55M | 79.79M | |
| Enterprise value | 41.77M | 50.36M | 60.84M | 49.82M | 79.9M | |
| P/E ratio | 2.45 | 2.06 | 7.48 | 2.04 | 5.6 | |
| Price to sales ratio | 1.72 | 2.46 | 3 | 2.11 | 3.28 | |
| POCF ratio | 12.83 | 9 | 55.99 | 10.74 | 16.06 | |
| PFCF ratio | 17.95 | 10.44 | 162.76 | 23.01 | 61.24 | |
| P/B Ratio | 1.42 | 1.57 | 1.8 | 1.28 | 1.92 | |
| PTB ratio | 1.42 | 1.57 | 1.8 | 1.28 | 1.92 | |
| EV to sales | 2.1 | 2.63 | 3.17 | 2.16 | 3.29 | |
| Enterprise value over EBITDA | 12 | 14.96 | 16.61 | 6.47 | 13.62 | |
| EV to operating cash flow | 15.61 | 9.65 | 59.13 | 11.02 | 16.08 | |
| EV to free cash flow | 21.84 | 11.2 | 171.87 | 23.61 | 61.32 | |
| Earnings yield | 0.1 | 0.12 | 0.03 | 0.12 | 0.04 | |
| Free cash flow yield | 0.06 | 0.1 | 0.01 | 0.04 | 0.02 | |
| Debt to equity | 0.38 | 0.28 | 0.24 | 0.18 | 0.15 | |
| Debt to assets | 0.23 | 0.19 | 0.17 | 0.13 | 0.11 | |
| Net debt to EBITDA | 2.14 | 1.02 | 0.88 | 0.16 | 0.02 | |
| Current ratio | 2.2 | 2.43 | 2.68 | 2.93 | 2.78 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0.76 | 0.92 | 0.53 | 0.76 | 1.39 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.09 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Research and developement to revenue | 0 | 0.01 | 0 | 0.01 | 0 | |
| Intangibles to total assets | 0.09 | 0.08 | 0.08 | 0.06 | 0.06 | |
| Capex to operating cash flow | -0.29 | -0.14 | -0.66 | -0.53 | -0.74 | |
| Capex to revenue | -0.04 | -0.04 | -0.04 | -0.1 | -0.15 | |
| Capex to depreciation | -0.9 | -0.82 | -0.75 | -2.62 | -3.72 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.23 | 0.32 | 0.19 | 0.36 | 0.29 | |
| ROIC | 0.08 | -0.1 | 0.05 | 0.12 | 0.08 | |
| Return on tangible assets | 0.1 | 0.14 | 0.05 | 0.12 | 0.07 | |
| Graham Net | -0.02 | -0.01 | 0 | 0.02 | 0.03 | |
| Working capital | 9.39M | 10.43M | 12.56M | 17.53M | 18.9M | |
| Tangible asset value | 20.59M | 26.41M | 28.49M | 34.6M | 38.34M | |
| Net current asset value | 1.81M | 3.23M | 6.12M | 11.86M | 14.01M | |
| Invested capital | 0.38 | 0.28 | 0.24 | 0.18 | 0.15 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 29.14 | 26.62 | 32.39 | 38.9 | 43.09 | |
| Days payables outstanding | 38.75 | 9.95 | 39.62 | 17.58 | 51.04 | |
| Days of inventory on hand | 50.57 | 41.2 | 55.91 | 71.33 | 64.99 | |
| Receivables turnover | 3.09 | 3.38 | 2.78 | 2.31 | 2.09 | |
| Payables turnover | 2.32 | 9.04 | 2.27 | 5.12 | 1.76 | |
| Inventory turnover | 1.78 | 2.18 | 1.61 | 1.26 | 1.38 | |
| ROE | 0.14 | 0.19 | 0.06 | 0.16 | 0.09 | |
| Capex per share | 0 | 0 | 0 | -0.01 | -0.02 |
IOF.L Frequently Asked Questions
What is Iofina plc stock symbol ?
Iofina plc is a GB stock and trading under the symbol IOF.L
What is Iofina plc stock quote today ?
Iofina plc stock price is $19.67 today.
Is Iofina plc stock public?
Yes, Iofina plc is a publicly traded company.
Company Profile
- Volume Average 213.84K
- Market Capitalization 39.91M
- Employee 95
- CEO Dr. Thomas Matthew Becker
- Headquarters London,GB
- IPO Date 2008-05-09
-
Website
https://www.iofina.com 
Iofina plc engages in the exploration and production of iodine, iodine specialty chemical derivatives, produced water, and natural gas in the United States and the United Kingdom. It offers halogen chemicals, disinfectants, electronic specialty gases, sanitizers, heat stabilizers, preservatives, and specialty intermediates, as well as animal health, mineral separation, and odor control products for use in electronics/semiconductor, pharmaceutical, food and beverage, personal care, paints and coatings, dairy, chemical intermediates, gemological, fish and wildlife, and nylon markets. The company also provides turnkey mid-stream fee based solutions to third party brine stream operators to extract iodine. Iofina plc was founded in 2005 and is based in London, the United Kingdom.
